OPTIMIZERX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.12 USD | +15.00% |
|
+8.58% | -29.28% |
| Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
| Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 145.6 | 470.8 | 1,104 | 288.2 | 259.8 | 184 | - |
| Enterprise Value (EV) 1 | 126.7 | 460.3 | 1,019 | 270 | 259.8 | 184 | 184 |
| P/E ratio | -44.7 x | -208 x | 3,106 x | -26.3 x | -13.9 x | -11.2 x | -18.9 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 5.92 x | 10.9 x | 18 x | 4.61 x | 3.63 x | 1.82 x | 1.63 x |
| EV / Revenue | 5.92 x | 10.9 x | 18 x | 4.61 x | 3.63 x | 1.82 x | 1.63 x |
| EV / EBITDA | -60.4 x | -2,356 x | 138 x | 52.4 x | - | 16.5 x | 13.2 x |
| EV / FCF | -44,809,904 x | -73,158,874 x | 1,470,104,553 x | - | - | - | - |
| FCF Yield | -0% | -0% | 0% | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 14,174 | 15,109 | 17,770 | 17,153 | 18,152 | 18,184 | - |
| Reference price 2 | 10.27 | 31.16 | 62.11 | 16.80 | 14.31 | 10.12 | 10.12 |
| Announcement Date | 2/27/20 | 2/24/21 | 2/15/22 | 3/8/23 | 4/15/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 24.6 | 43.31 | 61.29 | 62.45 | 71.52 | 101.4 | 113 |
| EBITDA 1 | -2.411 | -0.1998 | 7.997 | 5.497 | - | 11.14 | 13.99 |
| EBIT 1 | -3.694 | -2.135 | 0.3611 | -12.29 | -26.4 | -13.6 | -10.14 |
| Operating Margin | -15.02% | -4.93% | 0.59% | -19.68% | -36.91% | -13.42% | -8.97% |
| Earnings before Tax (EBT) 1 | -4.041 | -2.207 | 0.3781 | -11.44 | -25.16 | -18.4 | -14.13 |
| Net income 1 | -3.143 | -2.207 | 0.3781 | -11.44 | -17.57 | -18.4 | -14.13 |
| Net margin | -12.78% | -5.1% | 0.62% | -18.32% | -24.56% | -18.15% | -12.5% |
| EPS 2 | -0.2300 | -0.1500 | 0.0200 | -0.6400 | -1.030 | -0.9000 | -0.5350 |
| Free Cash Flow | -3.249 | -6.435 | 0.7507 | - | - | - | - |
| FCF margin | -13.21% | -14.86% | 1.22% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | 9.39% | - | - | - | - |
| FCF Conversion (Net income) | - | - | 198.57% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/24/21 | 2/15/22 | 3/8/23 | 4/15/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 16.12 | 20.3 | 13.73 | 13.98 | 15.09 | 19.7 | 13 | 13.82 | 16.33 | 28.37 | 18.13 | 20.9 | 26.02 | 35.7 | 20.33 |
| EBITDA 1 | 1.572 | 4 | -0.0983 | 0.6975 | 1.036 | 3.861 | -2.219 | -0.914 | 0.8807 | - | -1.658 | 0.4393 | 3.511 | 8.81 | - |
| EBIT 1 | 0.0382 | 0.6211 | -3.761 | -3.909 | -3.757 | -0.8644 | -7.063 | -4.882 | -3.553 | -10.9 | -9.3 | -6.7 | -3.1 | 5.5 | - |
| Operating Margin | 0.24% | 3.06% | -27.39% | -27.96% | -24.9% | -4.39% | -54.32% | -35.33% | -21.76% | -38.43% | -51.29% | -32.05% | -11.91% | 15.41% | - |
| Earnings before Tax (EBT) 1 | 0.0399 | 0.6235 | -3.761 | -3.885 | -3.467 | -0.3258 | -6.398 | -4.161 | -2.865 | -11.74 | -10.6 | -8 | -4.3 | 4.5 | - |
| Net income 1 | 0.0399 | 0.6 | -3.761 | -3.885 | -3.467 | -0.3 | -6.398 | -4.161 | -2.865 | -4.141 | -10.6 | -8 | -4.3 | 4.5 | - |
| Net margin | 0.25% | 2.96% | -27.39% | -27.79% | -22.98% | -1.52% | -49.2% | -30.12% | -17.54% | -14.6% | -58.46% | -38.27% | -16.52% | 12.61% | - |
| EPS 2 | - | 0.0300 | -0.2100 | -0.2100 | -0.1900 | -0.0200 | -0.3700 | -0.2400 | -0.1700 | -0.2400 | -0.4500 | -0.3900 | -0.1900 | 0.1200 | -0.1200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 2/15/22 | 5/4/22 | 8/9/22 | 11/8/22 | 3/8/23 | 5/10/23 | 8/14/23 | 11/6/23 | 4/15/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 18.9 | 10.5 | 84.7 | 18.2 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | -3.25 | -6.44 | 0.75 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | -0.1200 | - | - | - | - | - | - |
| Capex | - | - | 0.1 | - | - | - | - |
| Capex / Sales | - | - | 0.16% | - | - | - | - |
| Announcement Date | 2/27/20 | 2/24/21 | 2/15/22 | 3/8/23 | 4/15/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.12
USD
Average target price
16.17
USD
Spread / Average Target
+59.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.28% | 184M | |
| +18.66% | 414B | |
| +15.27% | 242B | |
| +12.15% | 144B | |
| +20.63% | 104B | |
| +17.19% | 83.87B | |
| +54.11% | 57.64B | |
| +33.59% | 53.37B | |
| +6.02% | 37.83B | |
| +15.88% | 32.51B |
- Stock Market
- Equities
- OPRX Stock
- Financials OptimizeRx Corporation
